NEW YORK, Nov. 29, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   NYSE Content Advisory: Pre-Market Update + American Express Marks Small Business Saturday jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2834310/NYSE_Market_Update_Nov_28.mp4’, image: ‘https://mma.prnasia.com/media2/2834310/NYSE_Market_Update_Nov_28.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Ashley Mastronardi delivers the pre-market update on November 28th

U.S. stocks are little changed Friday morning in a shortened session as traders return from Thanksgiving. The Dow is up about 2% for the week, while the S&P 500 has gained roughly 3%. Despite weekly gains, major averages remain on track to finish November lower amid recent volatility in AI-related stocks. American Express rings the opening bell ahead of Small Business Saturday, which has generated an estimated $223 billion since 2010.

Opening BellAmerican Express (NYSE: AXP) celebrates Small Business Saturday

Closing BellThe New York Stock Exchange Celebrates Kids Day

Click here to download the NYSE TV App

 

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160

BEIJING, April 30, 2026 /PRNewswire/ — Huahui Health today announced that it has…

GreenNode Joins Forces with Nvidia and Global Partners to Advance Generative AI Capabilities Across Asia Pacific

SINGAPORE, May 23, 2024 /PRNewswire/ — GreenNode, a member of VNG Digital…

Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate

Hu-mAtrIx™-Enabled Next-Generation ACVR2A/2B-Targeting Antibody Demonstrates Potential to Become a Best-in-Class Therapy for Obesity CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 18, 2026 /PRNewswire/ —…